Skip to main content
Search

# Antimicrobial resistance

3 related articles

Subscribe to updates
  1. bioRxiv

    BacLLM folds UniProt annotation knowledge into a protein language model, so sequence-only input can call resistance genes and rank phage candidates

    BacLLM injects semantic representations of UniProt annotations, encoded by a large language model, into an ESM-2 sequence encoder through cross-modal contrastive learning, so inference reads amino acid sequences alone. Across six resistance-prediction benchmarks, BacLLM (4B) beat Ankh, ESM-2, ProteinBERT and ProTrek in mean F1 under both logistic regression and an RBF-kernel support vector machine; on the SHV-1 β-lactamase P0AD64 it recovered six of eight experimentally supported resistance-attenuating sites among the top 65 ranked positions, while ESM-2 recovered none. The text branch is removed after training, so these gains come from sequence input, not annotation input.

  2. Preventing Surgical Site Infections: Ethical and Operational Imperatives for the Global Health Agenda

    This article reviews evidence and implementation experience on surgical site infection (SSI) prevention across infection prevention and control (IPC), antimicrobial stewardship (AMS), antimicrobial resistance (AMR), quality improvement, surveillance, safety culture, human factors, and emerging technologies, concluding that multimodal, context-adapted IPC interventions can substantially reduce SSI incidence without major capital investment, that persistent gaps remain in infrastructure, guideline implementation, surveillance, and environmental controls, that AMR further emphasizes the need to integrate AMS into surgical safety frameworks, and that artificial intelligence and objective diagnostic technologies may improve surveillance and early SSI detection, so that SSI prevention is both a

  3. Advanced Science

    AI-Guided Phenotypic Drug Repurposing Against Streptococcus pneumoniae

    This study applied AI-guided phenotypic drug repurposing to drug-resistant Streptococcus pneumoniae, using ensembles of transformer, graph, and tree models trained on 1849 actives and 34 503 inactives to prospectively examine 6747 drugs, selecting 11 candidate antibiotics of which nine strongly reduced in vitro growth of S. pneumoniae R6 (IC50 ≤ 0.4 µg/mL), with the most potent drugs thiostrepton and ceftiofur showing IC50 values of 0.0001 µg/mL (60.1 pM) and 0.0004 µg/mL (764 pM), respectively, and thiostrepton remaining highly potent against multidrug-resistant strains.

You’re all caught up